CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma Products LP v. Par Pharmaceutical Inc.

1:07-cv-00666

Overview

Case Number 1:07-cv-00666
Filing Date 2007-10-24
Status Terminated
Termination Date 2009-08-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

1 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Par Pharmaceutical Companies Inc. Operating Company

Represented By

1 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Ortho-McNeil Inc. Operating Company

Represented By

2 Attorneys Listed

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Biovail Laboratories International SRL Operating Company

Represented By

2 Attorneys Listed

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Purdue Pharma Products LP NPE (University / Research)

Represented By

1 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Napp Pharmaceutical Group Ltd. Operating Company

Represented By

1 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): πŸ‡©πŸ‡ͺ Germany GB πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2010-03-19
1:10-cv-00207

Purdue Pharma Products LP v. Anchen Pharmaceuticals Inc

U.S. Family Sibling (["US5591452", "US6326027"])
Status: DED
U.S. District Court 2007-05-09
1:07-cv-00255

Purdue Pharma Products LP v. Par Pharmaceuticals Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6254887
Controlled release tramadol
Filed: 1996-07-10
Issued: 2001-07-03
Expired (Term Ended)
Expires: 2016-07-10

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(19 total)
Pleading / Complaint

COMPLAINT filed against Par Pharmaceutical Inc., Par Pharmaceutical Companies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 149332.) - filed by Biovail Laboratories International SRL, Ortho-McNeil Inc., Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd.. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(ead) (Entered: 10/24/2007)

Entry #1 • 2007-10-24
1

Disclosure Statement pursuant to Rule 7.1 filed by Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd. identifying Napp Pharmaceutical Holdings Limited as Corporate Parent to Napp Pharmaceutical Group Ltd. (ead) (Entered: 10/24/2007)

Entry #2 • 2007-10-24
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead) (Entered: 10/24/2007)

Entry #3 • 2007-10-24
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,254,887; (ead) (Entered: 10/24/2007)

Entry #4 • 2007-10-24
1
Pleading / Complaint

SUMMONS Returned Executed by Biovail Laboratories International SRL, Ortho-McNeil Inc., Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd.. Par Pharmaceutical Companies Inc. served on 10/24/2007, answer due 11/13/2007. (Smith, Rodger) (Entered: 10/24/2007)

Entry #5 • 2007-10-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc